Premium
A Venture Capital View of Challenges, Opportunities, and Innovation in Biomedical Research
Author(s) -
Ratcliffe LT
Publication year - 2011
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.284
Subject(s) - venture capital , business , engineering ethics , engineering , finance
Small biotech companies have been an important source of innovation, pipelines, and new products for the pharmaceutical industry, and are primarily financed by venture capital (VC). The significant changes happening within the VC industry have broad implications for these small companies. This includes a shift to financing later‐stage programs with increasing interest in orphan or specialty indications. Nontraditional sources of capital and innovative risk‐sharing structures can enable early‐stage companies. Clinical Pharmacology & Therapeutics (2011) 89 2, 174–176. doi: 10.1038/clpt.2010.284